Table 2 Comparison between the CM group (n = 46) and the control group (n = 50) in the cognition and quality of life scales used at baseline
From: Preventive treatment can reverse cognitive impairment in chronic migraine
CM (n = 46) \(\overline{\mathbf{x}}\) (SD) | Control group (n = 50) \(\overline{\mathbf{x}}\) (SD) | P Value | |
|---|---|---|---|
Cognitive measures | |||
ROCF-c | 30.09 (5.4) | 33.1 (2.84) | 0.001 |
ROCF-m | 15.78 (7.01) | 23.22 (5.9) | 0.000 |
TMT-A | 56.79 (48.25) | 43.7 (38.72) | 0.016 |
TMT-B | 112.04 (49.99) | 90.84 (72.03) | 0.004 |
Emotional state | |||
HADS—A | 9.69 (4.04) | 5.35 (2.83) | 0.000 |
HADS—D | 7.91 (4.71) | 2.78 (2.54) | 0.000 |
BDI-II | 18.2 (13.4) | 5.2 (4.88) | 0.000 |
Quality of life | |||
SF-36 PF | 67.93 (22.42) | 90.5 (19.15) | 0.000 |
SF-36 RP | 20.65 (31.76) | 87.2 (28.98) | 0.000 |
SF-36 BP | 26.58 (23.16) | 86.75 (91.48) | 0.000 |
SF-36 GH | 39.24 (19.63) | 71.2 (16.65) | 0.000 |
SF-36 VT | 48.57 (81.38) | 64.27 (19.41) | 0.000 |
SF-36 SF | 53.53 (26.44) | 84.5 (20.6) | 0.000 |
SF- 36 RE | 42.78 (46.98) | 87.34 (26.87) | 0.000 |
SF-36 MH | 53.11 (19.61) | 75.32 (16) | 0.000 |
PSQI-GS | 10.49 (4.65) | 5.28 (3.47) | 0.000 |